510(k) Report

510(k) · Cleared

Recalled · Class III · 2018

Acon Urinalysis Reagent Strips

K061559510(k) TraditionalCleared Aug 11, 200667-day reviewClass I21 CFR 862.1785Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Acon Laboratories Co. · CDM Diazonium Colorimetry, Urobilinogen (Urinary, Non-Quant.)

Cleared on Aug 11, 2006 as substantially equivalent to K905396 (Heraeus Kulzer, Inc., 1991) and 1 other predicate after a 67-day review. Its family tree reaches back 1 generation to 1986. It has been recalled once.

Decided
Aug 11, 2006
Review
67 days
Class
Class I
Product code
CDM
Recalls
1
Predicates
2

Its longest line of descent runs back 1 generation to K861255 (1986). 2 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 1991: 1 other ancestorK861255 · Behring Rapignost Total Screen L Urine Test Strips · Behring Diagnostics, Inc. · 198619851990199520002005
Other ancestors, by generation 1 generation back: 1 other ancestor K861255 · Behring Rapignost Total Screen L Urine Test Strips · Behring Diagnostics, Inc. · 19860
  1. Root · 1 generation backK861255 Behring Rapignost Total Screen L Urine Test StripsBehring Diagnostics, Inc. · 1986
  2. This deviceK061559 Acon Urinalysis Reagent StripsAcon Laboratories Co. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K861255Behring Rapignost Total Screen L Urine Test StripsBehring Diagnostics, Inc.1986—
0 (this device)K061559Acon Urinalysis Reagent StripsAcon Laboratories Co.2006—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
FIG. 1 — Lineage of K061559, 1986–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CDM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K905396Hemastix Reagent Strips
Summary page 2
…id, Ascorbic, 2, 4-Dinitrophenylhydrazine (Spectrophotometric) Medical Specialty: Clinical Chemistry Predicate Device: Multistix 10 SG Reagent Strips for Urinalysis, K905396 Bayer Corporation, marketed by Bayer Corporation, located at Elkhart, IN 46515, USA. QuickVue UrinChek 10+SG, K861255 Quidel Co…
Heraeus Kulzer, Inc.1991—
*K861255Behring Rapignost Total Screen L Urine Test Strips
Summary page 2
…e: Multistix 10 SG Reagent Strips for Urinalysis, K905396 Bayer Corporation, marketed by Bayer Corporation, located at Elkhart, IN 46515, USA. QuickVue UrinChek 10+SG, K861255 Quidel Corporation, marketed by Quidel Corporation, located at San Diego, CA 92121, USA. Device Description: The ACON Urinalys…
Behring Diagnostics, Inc.1986—

Also cleared against K905396: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jun 22, 2018Class IIIZ-2786-2018Labeling designClarity Diagnostics LLC discovered specific lots of Clarity 10SG Strips are not compatible for use in the Clarity Urocheck 120 Urine Analyzers, due to lack of Canister Code Bar Code Label.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • 3 other devices also cite its predicate K905396.

How does its category compare?

All CDM devices

CDM Diazonium Colorimetry, Urobilinogen (Urinary, Non-Quant.): FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CDM

FDA has decided no CDM device since 2007.

Median 510(k) review, days · CDM

Too few CDM 510(k)s in any year since 2007 to give a median.

Recalls per year · CDM

No recall names CDM since 2007.

Adverse event reports per year · CDM

3in 2025

2012: 22013: 42014: 12015: 42017: 12018: 12022: 12023: 12024: 12025: 3
2007high 4 (2013) · low 0 (2007)2025

MAUDE reports naming product code CDM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—02
20130—04
20140—01
20150—04
20160—00
20170—01
20180—01
20190—00
20200—00
20210—00
20220—01
20230—01
20240—01
20250—03
20260—0—

What is it indicated for?

The ACON Urinalysis Reagent Strips (Urine) are for qualitative and semi-quantitative detection of one or more of the following analytes in urine: Glucose, Bilirubin, Ketone (Acetoacetic acid), Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, Leukocytes and Ascorbic Acid. The ACON Urinalysis Reagent Strips (Urine) are for single use in professional near-patient (point-of-care) and centralized laboratory locations. The strips are intended for…

Read the full statement (127 words)

The ACON Urinalysis Reagent Strips (Urine) are for qualitative and semi-quantitative detection of one or more of the following analytes in urine: Glucose, Bilirubin, Ketone (Acetoacetic acid), Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite, Leukocytes and Ascorbic Acid.

The ACON Urinalysis Reagent Strips (Urine) are for single use in professional near-patient (point-of-care) and centralized laboratory locations. The strips are intended for use in screening at-risk patients to assist diagnosis in the following areas:

Kidney function

Urinary track infections

Carbohydrate metabolism (e.g. diabetes mellitus)

Liver function

Acid-base balance

Urine concentration

The results can be used along with other diagnostic information to rule out certain disease states and to determine if microscopic analysis is needed. The test is to be read visually. It is intended for professional use only.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K061559: Acon Urinalysis Reagent Strips.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061559

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026